Latest filing published 14 Mar 2022 for Aprea Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Lars B. Abrahmsen: trading record in brief
Lars B. Abrahmsen is a declared insider of Aprea Therapeutics, Inc. (senior executive), with filings sourced from SEC (Form 4). We count 6 filings; the first trade dates from 25 February 2021 and the latest from 10 March 2022.
The open-market record consists of 2 sales worth €317k, with no purchase. Besides market trades, the filings include 2 share grants and 2 option exercises.
The record was last updated on 14 March 2022 with a share grant in Aprea Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Lars B. Abrahmsen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 24,700 shares0Common StockSEC:0001104659-22-033389:0
- 50,000 shares@ US$0.9267.0% of flowCommon StockSEC:0001104659-21-123186:0
- 25,000 shares@ US$0.9233.0% of flowCommon StockSEC:0001104659-21-118360:0
3 of 3 declarations